Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomas N Dam

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
International Journal of Dermatology|October 22, 2008
Teledermatology on the Faroe IslandsGregor B E Jemec, Michael Heidenheim, Tomas N Dam, et al.
Carcinogenesis|June 18, 2010
Topical application of valrubicin has a beneficial effect on developing skin tumorsStine M Andersen, Cecilia Rosada, Frederik Dagnaes-Hansen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 2, 2009
Amelioration of psoriasis by anti-TNF-alpha RNAi in the xenograft transplantation modelMaria Jakobsen, Karin Stenderup, Cecilia Rosada, et al.
Dermatology Reports|January 7, 2016
Exploring Valrubicin's Effect on Propionibacterium Acnes-Induced Skin Inflammation in Vitro and in VivoLouise Rottboell, Sarah de Foenss, Kenneth Thomsen, et al.
Acta Dermato-Venereologica|November 21, 2023
Response to Interleukin-17A Inhibitors According to Prior Biologic Exposures: A Danish Nationwide StudyNikolai Loft, Alexander Egeberg, Daniel Isufi, et al.
Clinical and Experimental Dermatology|March 25, 2026
Changes in Drug Survival of Adalimumab Over Time in Patients with Psoriasis - A Nationwide Cohort StudyGustav Hjort, Christopher W Schwarz, Lars E Bryld, et al.
BMC Dermatology|March 1, 2011
Targeting of human interleukin-12B by small hairpin RNAs in xenografted psoriatic skinRasmus O Bak, Karin Stenderup, Cecilia Rosada, et al.
Protein Engineering, Design & Selection : PEDS|August 15, 2015
AZ17: a new bispecific drug targeting IL-6 and IL-23 with potential clinical use--improves psoriasis in a human xenograft transplantation modelKarin Stenderup, Cecilia Rosada, Kurt Shanebeck, et al.
The Journal of Clinical Investigation|November 18, 2003
Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse modelLouise S Villadsen, Janine Schuurman, Frank Beurskens, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
International Journal of Dermatology|October 22, 2008
Teledermatology on the Faroe IslandsGregor B E Jemec, Michael Heidenheim, Tomas N Dam, et al.
Carcinogenesis|June 18, 2010
Topical application of valrubicin has a beneficial effect on developing skin tumorsStine M Andersen, Cecilia Rosada, Frederik Dagnaes-Hansen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 2, 2009
Amelioration of psoriasis by anti-TNF-alpha RNAi in the xenograft transplantation modelMaria Jakobsen, Karin Stenderup, Cecilia Rosada, et al.
Dermatology Reports|January 7, 2016
Exploring Valrubicin's Effect on Propionibacterium Acnes-Induced Skin Inflammation in Vitro and in VivoLouise Rottboell, Sarah de Foenss, Kenneth Thomsen, et al.
Acta Dermato-Venereologica|November 21, 2023
Response to Interleukin-17A Inhibitors According to Prior Biologic Exposures: A Danish Nationwide StudyNikolai Loft, Alexander Egeberg, Daniel Isufi, et al.
Clinical and Experimental Dermatology|March 25, 2026
Changes in Drug Survival of Adalimumab Over Time in Patients with Psoriasis - A Nationwide Cohort StudyGustav Hjort, Christopher W Schwarz, Lars E Bryld, et al.
BMC Dermatology|March 1, 2011
Targeting of human interleukin-12B by small hairpin RNAs in xenografted psoriatic skinRasmus O Bak, Karin Stenderup, Cecilia Rosada, et al.
Protein Engineering, Design & Selection : PEDS|August 15, 2015
AZ17: a new bispecific drug targeting IL-6 and IL-23 with potential clinical use--improves psoriasis in a human xenograft transplantation modelKarin Stenderup, Cecilia Rosada, Kurt Shanebeck, et al.
The Journal of Clinical Investigation|November 18, 2003
Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse modelLouise S Villadsen, Janine Schuurman, Frank Beurskens, et al.
Pageof 1